Quick Takeaways
- PRICE T ROWE ASSOCIATES INC /MD/ filed SCHEDULE 13G/A for IGM BIOSCIENCES INC COMMON STOCK (IGMS).
- Disclosed ownership: 0.2%.
- Date of event: 31 Jan 2025.
PRICE T ROWE ASSOCIATES INC /MD/ - 31 Jan 2025 SCHEDULE 13G/A Report for IGM BIOSCIENCES INC COMMON STOCK (IGMS)
- Filing Manager
- PRICE T ROWE ASSOCIATES INC /MD/
- Reporting Manager
- T. Rowe Price Associates, Inc.
- Security
- IGM BIOSCIENCES INC COMMON STOCK
- Symbol
- IGMS
- Disclosed Ownership
- 65,940 shares
- Ownership
- 0.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 07 Feb 2025, 11:55:05 UTC
- Date of event
- 31 Jan 2025
- Previous filing
- 14 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"PRICE T ROWE ASSOCIATES INC /MD/ disclosed 0.2% ownership in IGM BIOSCIENCES INC COMMON STOCK (IGMS) on 31 Jan 2025."
What Changed
- Previous schedule filing date: 14 Feb 2025.
- Current filing was accepted on 07 Feb 2025, 11:55.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Associates, Inc. | 0.2% | 65,940 | 65,940 | 0 | Ellen York | Vice President |